Synthetic Biologics Inc

ASE:SYN  
0.37
0.00 (0.00%)
Regulatory, Earnings Announcements

Synthetic Biologics Reports 2020 Q3 Financial Results

Published: 11/10/2020 21:40 GMT
Synthetic Biologics Inc (SYN) - Synthetic Biologics Reports 2020 Third Quarter Operational Highlights and Financial Results.
Synthetic Biologics Inc Qtrly Loss per Share $0.14.
Synthetic Biologics Inc - Qtrly Loss per Share $0.14.
Synthetic Biologics - Received FDA Notice That Syn-004 Phase 1b/2a Clinical Program in Adult Allogeneic Hct Recipients May Proceed As Planned.
Synthetic Biologics- Syn-004 Phase 1b/2a Clinical Trial Commencement Anticipated in Q1 2021.